Single-center Comparison of Three Chemoembolization Regimens for Hepatocellular Carcinoma
Authors:
- Nicholas J. PetruzziNPNicholas J. Petruzzi
- Andrea J. FrangosAFAndrea J. Frangos
- Jonathan M. FenkelJFJonathan M. Fenkel
- Steven K. HerrineSHSteven K. Herrine
- Hie-Won HannHHHie-Won Hann
- Ernest L. RosatoERErnest L. Rosato
- David J. EschelmanDEDavid J. Eschelman
- Carin F. GonsalvesCGCarin F. Gonsalves
- Daniel B. BrownDBDaniel B. Brown
- 1 February 2013
- journal article
- research article
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 24 (2) , 266-273
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Alpha-fetoprotein response correlates with EASL response and survival in solitary hepatocellular carcinoma treated with transarterial therapies: A subgroup analysisJournal of Hepatology, 2012
- Local tumor progression following lipiodol-based targeted chemoembolization of hepatocellular carcinoma: a retrospective comparison of miriplatin and epirubicinCancer Management and Research, 2012
- Radiographic Response to Locoregional Therapy in Hepatocellular Carcinoma Predicts Patient Survival TimesGastroenterology, 2011
- Radioembolization Results in Longer Time-to-Progression and Reduced Toxicity Compared With Chemoembolization in Patients With Hepatocellular CarcinomaGastroenterology, 2011
- Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocelluar carcinoma (HCC)Journal of Surgical Oncology, 2010
- Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V StudyCardioVascular and Interventional Radiology, 2009
- Outcomes of Neoadjuvant Transarterial Chemoembolization to Downstage Hepatocellular Carcinoma Before Liver TransplantationAnnals of Surgery, 2008
- CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatmentSeminars in Radiation Oncology, 2003
- Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trialThe Lancet, 2002
- Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL ConferenceJournal of Hepatology, 2001